CDKN2A and head and neck squamous cell carcinoma: In their work Karpathiuo et al. [29] compare the expression of p16 and p53 (null, ≥ 50% positive) IHC in HNSCC and show that 13 out of 25 (52%) p16 positive SCCs are p53 abnormal.